| Nissan Chemical Corporation | |
| Native Name: | 日産化学株式会社 |
| Native Name Lang: | ja |
| Type: | Public (K.K) |
| Traded As: | Nikkei 225 Component |
| Isin: | JP3670800006 |
| Founder: | Jokichi Takamine Eiichi Shibusawa Takashi Masuda |
| Hq Location City: | Nihonbashi, Chuo-ku, Tokyo 103-6119 |
| Hq Location Country: | Japan |
| Key People: | Kojiro Kinoshita (President and CEO) |
| Industry: | Chemicals |
| Revenue: | JPY 193.4 billion (FY 2017) (US$ 1.8 billion) |
| Net Income: | JPY 27.1 billion (FY 2017) (US$ 255 million) |
| Num Employees: | 2,583 (consolidated, as of March 31, 2019) |
| Area Served: | Worldwide |
| Footnotes: | [1] [2] [3] |
is a Japanese company and constituent of the Nikkei 225 stock index.[4]
The company was founded in 1887 as the Tokyo Jinzo Hiryo (Tokyo Artificial Fertilizer Company) by Jokichi Takamine, Eiichi Shibusawa and Takashi Masuda.[5] Takamine served as chief technical advisor for the company, which later was renamed to Dai Nippon Artificial Fertilizer Company.[6] The company changed the corporate name from Nissan Chemical Industries, Ltd. to Nissan Chemical Corporation on July 1, 2018.
The four main businesses of Nissan Chemical are Chemicals, Performance Materials, Agricultural Materials and Pharmaceuticals. Among the company's products are LCD display materials such as SUNEVER® and an external antiparasite drug for animals called Fluralaner, which is an active ingredient in the veterinary pharmaceutical "BRAVECTO®", developed by MSD Animal Health (MSD), the global animal health business of Merck & Co., Ltd.